AAAAAA
Results:
1-25
|
Results: 25
Authors:
Feuerer, M
Beckhove, P
Bai, LH
Solomayer, EF
Bastert, G
Diel, IJ
Pedain, C
Oberniedermayr, M
Schirrmacher, V
Umansky, V
Citation: M. Feuerer et al., Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow, NAT MED, 7(4), 2001, pp. 452-458
Authors:
Schirrmacher, V
Citation: V. Schirrmacher, T-cell immunity in the induction and maintenance of a tumour dormant state, SEM CANC B, 11(4), 2001, pp. 285-295
Authors:
Schirrmacher, V
Griesbach, A
Ahlert, T
Citation: V. Schirrmacher et al., Antitumor effects of Newcastle disease virus in vivo: local versus systemic effects, INT J ONCOL, 18(5), 2001, pp. 945-952
Authors:
Chlichlia, K
Bahgat, M
Ruppel, A
Schirrmacher, V
Citation: K. Chlichlia et al., DNA vaccination with asparaginyl endopeptidase (Sm32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice, VACCINE, 20(3-4), 2001, pp. 439-447
Authors:
Umansky, V
Schirrmacher, V
Citation: V. Umansky et V. Schirrmacher, Nitric oxide-induced apoptosis in tumor cells, ADV CANC R, 82, 2001, pp. 107-131
Authors:
Feuerer, M
Rocha, M
Bai, LH
Umansky, V
Solomayer, EF
Bastert, G
Diel, IJ
Schirrmacher, V
Citation: M. Feuerer et al., Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients, INT J CANC, 92(1), 2001, pp. 96-105
Authors:
Umansky, V
Ratter, F
Lampel, S
Bucur, M
Schirrmacher, V
Ushmorov, A
Citation: V. Umansky et al., Inhibition of nitric-oxide-mediated apoptosis in Jurkat leukemia cells despite cytochrome c release, EXP CELL RE, 265(2), 2001, pp. 274-282
Authors:
Muerkoster, S
Laman, JD
Rocha, M
Umansky, V
Schirrmacher, V
Citation: S. Muerkoster et al., Functional and in situ evidence for nitric oxide production driven by CD40-CD40L interactions in graft-versus-leukemia reactivity, CLIN CANC R, 6(5), 2000, pp. 1988-1996
Authors:
Schirrmacher, V
Bai, LH
Umansky, V
Yu, LH
Xing, Y
Qian, ZC
Citation: V. Schirrmacher et al., Newcastle Disease Virus activates macrophages for anti-tumor activity, INT J ONCOL, 16(2), 2000, pp. 363-373
Authors:
Schirrmacher, V
Forg, P
Dalemans, W
Chlichlia, K
Zeng, Y
Fournier, P
von Hoegen, P
Citation: V. Schirrmacher et al., Infra-pinna anti-tumor vaccination with self-replicating infectious RNA orwith DNA encoding a model tumor antigen and a cytokine, GENE THER, 7(13), 2000, pp. 1137-1147
Authors:
Termeer, CC
Schirrmacher, V
Brocker, EB
Becker, JC
Citation: Cc. Termeer et al., Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells, CANC GENE T, 7(2), 2000, pp. 316-323
Authors:
Schirrmacher, V
Citation: V. Schirrmacher, Anti-tumor vaccination, ZBL CHIR, 125, 2000, pp. 33-36
Authors:
Schirrmacher, V
Muerkoster, S
Bucur, M
Umansky, V
Rocha, M
Citation: V. Schirrmacher et al., Breaking tolerance to a tumor-associated viral superantigen as a basis forgraft-versus-leukemia reactivity, INT J CANC, 87(5), 2000, pp. 695-706
Authors:
Schirrmacher, V
Citation: V. Schirrmacher, In situ analysis of tumor-specific CTL effector and memory responses elicited by tumor vaccination, INT J ONCOL, 15(2), 1999, pp. 217-227
Authors:
Jurianz, K
Von Hoegen, P
Schirrmacher, V
Citation: K. Jurianz et al., Immunological and molecular characterization of an aggressive murine lymphoma variant: Modulation in vitro and in vivo, INT J ONCOL, 15(1), 1999, pp. 71-79
Authors:
Schirrmacher, V
Jurianz, K
Roth, C
Griesbach, A
Bonifer, R
Zawatzky, R
Citation: V. Schirrmacher et al., Tumor stimulator cell modification by infection with Newcastle Disease Virus: Analysis of effects and mechanism in MLTC-CML cultures, INT J ONCOL, 14(2), 1999, pp. 205-215
Authors:
Schirrmacher, V
Haas, C
Bonifer, R
Ahlert, T
Gerhards, R
Ertel, C
Citation: V. Schirrmacher et al., Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus, GENE THER, 6(1), 1999, pp. 63-73
Authors:
Haas, C
Herold-Mende, C
Gerhards, R
Schirrmacher, V
Citation: C. Haas et al., An effective strategy of human tumor vaccine modification by coupling bispecific costimulatory molecules, CANC GENE T, 6(3), 1999, pp. 254-262
Authors:
Ushmorov, A
Ratter, F
Lehmann, V
Droge, W
Schirrmacher, V
Umansky, V
Citation: A. Ushmorov et al., Nitric oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release, BLOOD, 93(7), 1999, pp. 2342-2352
Authors:
Muerkoster, S
Rocha, M
Crocker, PR
Schirrmacher, V
Umansky, V
Citation: S. Muerkoster et al., Sialoadhesin-positive host macrophages play an essential role in graft-versus-leukemia reactivity in mice, BLOOD, 93(12), 1999, pp. 4375-4386
Authors:
Muerkoster, S
Wachowski, O
Zerban, H
Schirrmacher, V
Umansky, V
Rocha, M
Citation: S. Muerkoster et al., Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages, CLIN CANC R, 4(12), 1998, pp. 3095-3106
Authors:
Haas, C
Ertel, C
Gerhards, R
Schirrmacher, V
Citation: C. Haas et al., Introduction of adhesive and costimulatory immune functions into tumor cells by infection with Newcastle Disease Virus, INT J ONCOL, 13(6), 1998, pp. 1105-1115
Authors:
Kruger, A
Schirrmacher, V
Khokha, R
Citation: A. Kruger et al., The bacterial lacZ gene: An important tool for metastasis research and evaluation of new cancer therapies, CANC METAST, 17(3), 1998, pp. 285-294
Authors:
Schirrmacher, V
Ahlert, T
Probstle, T
Steiner, HH
Herold-Mende, C
Gerhards, R
Hagmuller, E
Citation: V. Schirrmacher et al., Immunization with virus-modified tumor cells, SEMIN ONCOL, 25(6), 1998, pp. 677-696
Authors:
Muller, M
Gounari, F
Prifti, S
Hacker, HJ
Schirrmacher, V
Khazaie, K
Citation: M. Muller et al., EblacZ tumor dormancy in bone marrow and lymph nodes: Active control of proliferating tumor cells by CD8(+) immune T cells, CANCER RES, 58(23), 1998, pp. 5439-5446
Risultati:
1-25
|